Assure Holdings Corp. ("Assure" or the “Company”)(TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, closed a US$ 10.5 million brokered private placement from US institutional investors (the "Offering"). As part of the Offering, Assure issued 16,357,703 units (each, a “Unit” and collectively, the “Units”) at a price of US$0.64 per Unit. Each Unit consisted of one common share in the capital of Assure (each, a “Common Share” and collectively, the “Common Shares”) and one common share purchase warrant (each, a “Warrant” and collectively, the “Warrants”). Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of US$0.78 for a period of five years from the date of issuance. The Offering was led by The Benchmark Company, LLC, a leading healthcare-focused US investment bank.
Minden Gross LLP acted for Assure with a team led by Andrew Elbaz (Partner), Alexander Katznelson (Associate), and Darren Nguyen (Associate) from Minden Gross LLP's Securities and Capital Markets Group
Read the media release here: